Letters to the Editor
August 3, 2020
Vol. 90 No. 3 (2020)
SLE presenting as DAH and relapsing as refractory retinitis
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
856
Views
579
Downloads
Authors
Dear Editor,
A 17-year-old boy, diagnosed with Systemic Lupus Erythematosus (SLE), presented to ophthalmology department with gradual painless diminution of vision in both eyes (right more than left). He had already received 6 pulses of cyclophosphamide and steroids at monthly intervals one year back for diffuse alveolar hemorrhage (DAH) and was on maintenance oral 40 mg prednisolone and 3 grams mycophenolate mofetil (MMF). There was no history of oliguria, skin rash, joint pain, oral ulcers, photosensitivity or any neurological deficit in this presentation. There was no proteinuria, hematuria or worsening of renal function.
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
“SLE Presenting As DAH and Relapsing As Refractory Retinitis”. 2020. Monaldi Archives for Chest Disease 90 (3). https://doi.org/10.4081/monaldi.2020.1250.